Media-OutReach Newswire Chuangxinzhong, a Wholly-Owned Subsidiary of Yeahka, Accelerates AI Marketing with Rapid Growth in 2024 Performance
HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment 1.